We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DC4 market cap is 25.35B. The company's latest EPS is USD 1.4745 and P/E is 47.68.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.93B | 2.45B | 2.91B | 3.62B | 4.03B |
| Operating Income | 299.5M | 277.4M | 391.2M | 598.4M | 605.1M |
| Net Income | 493.6M | 154.7M | 341.2M | 541.5M | 576.2M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.29B | 4.86B | 5.39B | 6.26B | 6.48B |
| Total Liabilities | 2.46B | 2.61B | 3.26B | 4.2B | 4.38B |
| Total Equity | 1.83B | 2.25B | 2.13B | 2.07B | 2.1B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 475.6M | 442.5M | 669.5M | 748.5M | 989.5M |
| Investing | -1.02B | -216.1M | -521.5M | -507.2M | -207.5M |
| Financing | 912.1M | 10.4M | -552.5M | -318.6M | -734.8M |
| Market Cap | 25.35B |
| Price to Earnings Ratio | 47.68 |
| Price to Sales Ratio | 6.81 |
| Price to Cash Ratio | 45.33 |
| Price to Book Ratio | 13.07 |
| Dividend Yield | - |
| Shares Outstanding | 390.77M |
| Average Volume (1 week) | 2.19k |
| Average Volume (1 Month) | 1.67k |
| 52 Week Change | -46.21% |
| 52 Week High | 131.80 |
| 52 Week Low | 55.01 |
| Spread (Intraday) | 0.16 (0.25%) |
| Company Name | Dexcom Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dexcom.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
